ArticleCommunications medicine2026

Sequential versus upfront oxaliplatin-based therapy in metastatic colorectal cancer: long-term outcomes of a randomized phase 3 trial.

Makoto Okawaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.